Patheon buyout brings Thermo into contract manufacturing
$7.2bn deal expands Thermo Fisher’s laboratory products and services segment
Laboratory supplies behemoth Thermo Fisher Scientific has agreed to buy contract development and manufacturing organisation Patheon for $7.2 billion (£5.6 billion) including assuming around $2 billion of Patheon’s debt.